Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection
暂无分享,去创建一个
G. Cooke | G. Dore | C. Orkin | K. Petoumenos | S. Bhagani | E. Gane | J. Grebely | M. Nelson | M. Martinello | G. Matthews | E. Tu | P. Marks | T. Applegate | N. Pagani | Edward Gane | Gregory J. Dore | Kathy Petoumenos | Sanjay Bhagani | Elise Tu | Graham S Cooke | C. Orkin | Mark R. Nelson